[Form 4] Encompass Health Corporation Insider Trading Activity

Rhea-AI Filing Summary

Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corporation (EHC), reported multiple non‑derivative transactions on 08/21/2025. The filing shows transfers involving common stock: 27,480 shares were disposed of by the reporting person’s spouse and simultaneously 27,480 shares were acquired by an irrevocable trust in which the reporting person is a beneficiary. After these moves the reporting person reports 37,749 shares beneficially owned via spouse and 125,631 shares indirectly held by an irrevocable trust for the benefit of children; the reporting person disclaims beneficial ownership of the spouse‑held shares. The report was signed by an attorney‑in‑fact.

Positive

• Transfers were to related trusts/spouse, indicating estate or family planning rather than open‑market sales

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider moved shares into family trusts; transactions are transfers, not open‑market buys or sales.

The Form 4 shows routine intra‑family and trust transfers by the reporting person’s spouse and an irrevocable trust rather than market purchases or public sales. The net effect disclosed is a reallocation of beneficial ownership among related parties: 27,480 shares moved to an irrevocable trust for which the reporting person is a beneficiary, while 37,749 shares remain reported as held by the spouse with a disclaimer of beneficial ownership by the reporting person. These are governance/estate‑planning style transfers with no cash proceeds reported.

Corporate Governance Expert

TL;DR: Actions appear consistent with estate planning; disclosure and disclaimer are included.

The filing includes an explicit disclaimer of beneficial ownership for shares held by the spouse and documents transfers to trusts, which aligns with common insider reporting practices to reflect indirect holdings and fiduciary arrangements. The inclusion of an attorney‑in‑fact signature indicates the filing was executed by an authorized representative. No derivative transactions or sales for cash are reported, and the filing provides the explanations required under Section 16 disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COLTHARP DOUGLAS E

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	08/21/2025		G(1)		27,480	D	$0	37,749(2)	I	By spouse
Encompass Health Common Stock	08/21/2025		G(1)		27,480	A	$0	27,480	I	By irrevocable trust
Encompass Health Common Stock								60,335	D
Encompass Health Common Stock								125,631	I	By irrevocable trust for the benefit of children

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction involved the reporting person's spouse transferring shares of EHC common stock to a trust in which the reporting person is a beneficiary.

2. The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

	/S/ Stephen Leasure, attorney-in-fact for Douglas Coltharp	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Douglas E. Coltharp report on Form 4 for EHC?

The filing reports transfers dated 08/21/2025 involving Encompass Health common stock, including 27,480 shares transferred by the reporting person’s spouse and 27,480 shares acquired by an irrevocable trust of which the reporting person is a beneficiary.

How many EHC shares does the report show as indirectly owned after the transactions?

The Form 4 reports 37,749 shares as held by the spouse (reporting person disclaims beneficial ownership) and 125,631 shares indirectly held by an irrevocable trust for the benefit of children.

Were any shares sold for cash in this Form 4 for EHC?

No cash sales are reported. The transactions are coded as transfers (Code G) with Price $0, indicating transfers to trusts/spouse rather than market sales.

Does the filing include derivative transactions or option exercises for EHC?

No. Table II for derivative securities contains no entries; only non‑derivative common stock transfers are reported.

Who signed the Form 4 filed for Douglas E. Coltharp?

The Form 4 was signed on behalf of Douglas E. Coltharp by Stephen Leasure, attorney‑in‑fact, dated 08/21/2025.